Figure 5.
Figure 5. KRASG12D-induced aberrant growth of lung CD11bint CD11cdim Gr1−cells. (A) Flow cytometry profiling of lung myeloid cells in noninduced KRASLSL-G12D mice. CD45+ gated lung hematopoietic cells contain CD11blowCD11c+ (Fr-1), CD11bintCD11cdimGr1− (Fr-2), CD11bintCD11c-Gr1int (Fr-3), and CD11bhighGr1high (Fr-4) myeloid populations. Gr1 expression profiles of the 4 myeloid populations are indicated in the bottom CD11c/Gr1 contour plot. (B) PCR detection of recombination of the KRASG12D allele in the sorted myeloid populations (Fr-1 to 4 from noninduced KRASLSL-G12D mice) infected with AdCMVCre or AdCMVβgal at MOI = 100 for 72 hours. (C) Representative phase-contrast images of AdCMVβgal or AdCMVCre-infected Fr-1/2 cells (sorted from noninduced KRASLSL-G12D mice) cultured on lung fibroblast feeders for 4 weeks. Original magnification ×200. (D) Flow cytometry analysis of noninduced Fr-1/2 cells for DC marker expression.

KRASG12D-induced aberrant growth of lung CD11bintCD11cdimGr1cells. (A) Flow cytometry profiling of lung myeloid cells in noninduced KRASLSL-G12D mice. CD45+ gated lung hematopoietic cells contain CD11blowCD11c+ (Fr-1), CD11bintCD11cdimGr1 (Fr-2), CD11bintCD11c-Gr1int (Fr-3), and CD11bhighGr1high (Fr-4) myeloid populations. Gr1 expression profiles of the 4 myeloid populations are indicated in the bottom CD11c/Gr1 contour plot. (B) PCR detection of recombination of the KRASG12D allele in the sorted myeloid populations (Fr-1 to 4 from noninduced KRASLSL-G12D mice) infected with AdCMVCre or AdCMVβgal at MOI = 100 for 72 hours. (C) Representative phase-contrast images of AdCMVβgal or AdCMVCre-infected Fr-1/2 cells (sorted from noninduced KRASLSL-G12D mice) cultured on lung fibroblast feeders for 4 weeks. Original magnification ×200. (D) Flow cytometry analysis of noninduced Fr-1/2 cells for DC marker expression.

Close Modal

or Create an Account

Close Modal
Close Modal